the global crisis of depression - lundbeck depression... · the global crisis of depression ... the...

Join the conversation

@EconomistEvents

#depressionsummit

Copyright © 2014 The Economist Group. All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission of The Economist Group. Whilst every effort has been taken to verify the accuracy of information presented at this conference, neither The Economist Group nor its affiliates can accept any responsibility or liability for reliance by any person on this information.

The Economist EventsThe Economist Events is a part of The Economist Group, publisher of The Economist newspaper. Sharing The Economist’s commitment to informed, impartial and independent debate, we are recognised the world over as a leading provider of highly interactive meetings—including industry conferences, private gatherings and government roundtables—for senior executives seeking new insights into important strategic issues.

20 Cabot Square, London, E14 4QW, United Kingdom Web www.economistevents.com • Phone +44 (0) 207 576 8000 • Fax +44 (0) 207 576 8472

S P O N S O R E D B Y :

THE GLOBAL CRISIS OF DEPRESSIONTHE LOW OF THE 21ST CENTURY?

TUESDAY, NOVEMBER 25TH 2014 KINGS PLACE, LONDON

O F F I C I A L P R A G E N C Y :

www.depression.economist.com


WEL

COM

E

MEDIA PACK

THE GLOBAL CRISIS OF DEPRESSIONTHE LOW OF THE 21ST CENTURY?

November 25th 2014

PRESS REGISTRATION Registration starts at: 08:15. There will be a separate desk located in the registration area clearly marked: ‘PRESS’. Please bring your business/press card with you and valid ID. For security reasons if somebody else will be attending in your place please let us know prior to the event. Only accredited press will be allowed to attend the summit.

WI-FI AND INTERNET ACCESS This is free for all conference attendees. Please use the following wifi login details:

Username: mentalhealth Password: november

A dedicated press room is available where you can charge your laptop/ tablet if needed.

SOCIAL MEDIA We will be tweeting live from the event. If you are a Twitter user we encourage you to tweet using the following hashtag: #depressionsummit. You can also follow us on @EconomistEvents.

LUNCH AND REFRESHMENTS Refreshments will be served in the press room. Press are invited to attend lunch together with delegates and there will be tables reserved for press.

ACCESS TO SESSIONS Press are invited to attend all sessions. An area in the back of the conference room will be clearly marked for press. Any photos taken inside conference room should be taken before the session starts.

There will be a designated area to conduct any speaker interviews and take photos after the session.

CONTACTS For further information, please contact Edelman at [email protected] or tel: 0203 047 2343.

PRO

GRA

MM

E

www.depression.economist.com@EconomistEvents #depressionsummit

PRO

GRA

MM

E

08.15 REGISTRATION AND REFRESHMENTS

09.00 CHAIR’S WELCOME AND INTRODUCTORY REMARKS

John Andrews, Consultant Editor, The Economist

A STRONG ECONOMIC AND SOCIAL CASE FOR PREVENTING, CONTROLLING AND MANAGING DEPRESSION

09.10 SPECIAL ADDRESS: THE BURDEN OF DEPRESSION

Kofi Annan, Former Secretary General, United Nations; Chairman, Kofi Annan Foundation

09.50 KEYNOTE ADDRESS: THE POLITICAL IMPERATIVES TO ADDRESS MENTAL HEALTH AND DEPRESSION

RT Hon Norman Lamb MP, Minister of State for Care and Support, Department of Health, United Kingdom

10.20 NETWORKING AND REFRESHMENT BREAK

FIGHTING DEPRESSION – THE CASE FOR PREVENTION AND HEALTH PROMOTION IN DEPRESSION

10.50 OPENING KEYNOTE

Nick Hækkerup, Minister of Health, Denmark

11.10 CARRYING THE WEIGHT: THE BURDEN OF DEPRESSION AND KEY TRENDS FOR THE FUTURE, INCLUDING THE ECONOMIC COSTS OF THE ILLNESS

Hans-Ulrich Wittchen, Chairman and Director, Institute of Clinical Psychology and Psychotherapy; Center of Clinical Epidemiology and Longitudinal Studies (CELOS), Dresden Technical University

11.30 INTERVIEW: UNDERSTANDING THE COMPLEXITY OF DEPRESSION AND OF TREATING DEPRESSION

Simon Wessely, Professor of Psychological Medicine at the Institute of Psychiatry, King’s College

11.55 FINDING A KEY TO BEATING DEPRESSION: A PERSONAL STORY

David Kinder, Deputy Director, Workforce, Pay and Pensions, Public Spending Group, HM Treasury

12.15 NETWORKING LUNCH

FIGHTING BACK – HOW SHOULD DEPRESSION ACROSS ALL STRATA OF SOCIETY BE TREATED IN THE 21ST CENTURY?

13.15 OPENING PANEL DISCUSSION: FUTURE TOOLS FOR PATIENT TREATMENT

This opening panel discussion will feature three stakeholders representing the NHS, the

physician and the manufacturer. It has been over a decade since a new antidepressant has

been launched. Psychiatric and CNS research has largely been curtailed in Europe due to the

risk involved in this therapeutic area. Where will better treatment or even a cure come from?

How should policy makers, society and the industry work together to incentivise and develop

a step change in treatment? What role do financial incentives have in the future of

developing cures for depression? What is the future for non-pharmacological treatments?

How important is primary care?

David Haslam CBE, Chair, NICE (National Institute for Health and Care Excellence)

David Nutt, Professor of Neuropsychopharmacology, Imperial College, UK; President, European Brain Counci (EBC)

Ulf Wiinberg, Chief Executive Officer, Lundbeck, Denmark

14.00 PANEL DISCUSSION: THE PATIENT RESPONSE

Depression is a complex problem, with different patients requiring different treatments. This

high-level panel will look at what we can and should do as depression becomes an even

greater issue in Europe, with discussions on the role of prevention, health promotion, talking

therapies and medical solutions, and how to fill existing treatment gaps.

Mary G Baker, Immediate Past-president, European Brain Council (EBC)

George N Christodoulou, Professor of Psychiatry and Chairman of the Department of Psychiatry, University of Athens, Greece; President, World Federation of Mental Health (WFMH)

Christopher Dowrick, Professor of Primary Medical Care, University of Liverpool

Ulrich Hegerl, President, European Alliance against Depression; Chair and Medical Director of the Department of Psychiatry, Leipzing University

Moderated by: Linda Rosenberg, President and Chief Executive Officer, National Council for Behavioral Health, USA

14.45 NETWORKING AND REFRESHMENT BREAK

THE CHALLENGE OF DEPRESSION IN THE WORKPLACE

15.15 AN EMPLOYER’S PERSPECTIVE

Lord Dennis Stevenson, former Chair, HBOS, Trustee, MQ: Transforming Mental Health


PRO

GRA

MM

E

SPEA

KERS

’ BIO

GRA

PHIE

S15.30 REMARKS ON THE IMPACT OF DEPRESSION AND MENTAL ILLNESS TO WORKPLACE HEALTH AND ECONOMY

Elisabeth Svantesson, Deputy Chair, Committee on Social Insurance, Parliament, Sweden

15.45 PANEL DISCUSSION

Depression is a leading cause of productivity loss in Europe, with both absenteeism and

presenteeism caused by work-place stress and anxiety. This panel looks at the causes and

impacts of this complex yet all too common problem.

Ulrich Birner, Head of Psychosocial Health and Well-being, Siemens

Louise Bradley, President and Chief Executive Officer, Mental Health Commission of Canada

Steve Evison, Chairman, European Federation of Employers; Director, Employee Affairs. EMEA, Ford Motor Company

Andreas Tautz, Chief Medical Officer, Deutsche Post, DHL

Moderated by: Sue Baker, Director, Time to Change

CLOSING SPEECH AND PANEL DISCUSSION

16.30 CLOSING KEYNOTE ADDRESS

Alastair Campbell, Communicator, Writer and Strategist

16.50 PANEL DISCUSSION: FACING DOWN DEPRESSION; ENGENDERING A GLOBAL RESPONSE TO A GLOBAL PUBLIC HEALTH CRISIS

Beatrice Lorenzin, Minister of Health, Italy

Francesca Colombo, Head of Health Division, OECD

Patrick Mcgorry, Professor, Centre for Youth Mental Health, University of Melbourne

Linda Rosenberg, President and Chief Executive Officer, National Council for Behavioral Health

17.30 CHAIR’S CLOSING REMARKS

John Andrews, Consultant Editor, The Economist

17.40 CLOSE AND DRINKS RECEPTION

CHAIR

JOHN ANDREWS

Consultant Editor

The Economist

Until moving back to London in November 2006, John Andrews was The Economist’s most experienced

Foreign Correspondent. In a 24-year career that included positions in London as Industry Editor and

Asia Editor, his foreign postings have ranged from Singapore and Hong Kong to Brussels, Washington

DC, Paris and finally Los Angeles. Before joining The Economist, Mr Andrews spent six years with the

Guardian and led the paper’s coverage of OPEC during its 1979 to 1982 heyday. He came to the

Guardian after living for seven years in the Arab world, first as an academic in Libya and Lebanon and

then as a journalist. Working for NBC News he covered the Middle East peace–shuttle of Henry Kissinger

and the first year of the Lebanese civil war. Mr Andrews has written two books on Asia, Co-authored a

book on Europe and contributed chapters to other books, including the “Encyclopaedia Britannica”.

His latest book is “The Economist Book of Isms”.

@TheEconomist

SPEAKERS

KOFI A ANNAN

Former Secretary General, United Nations;Chairman, Kofi Annan Foundation

Kofi A Annan was the 7th Secretary-General of the United Nations and is the Founder and Chair of the

Kofi Annan Foundation. One of his main priorities as Secretary-General was a comprehensive programme

of reform that sought to revitalise the United Nations and make the international system more effective.

He was a constant advocate for human rights, the rule of law, the Millennium Development Goals and

Africa, and sought to bring the organisation closer to the global public by forging ties with civil society,

the private sector and other partners. In 2001, he and the United Nations were jointly awarded the Nobel

Prize for Peace. Mr Annan Chaired the Global Commission on Elections, Democracy and Security, and in

January 2013, launched the West Africa Commission on Drugs, as a response to the surge in drug

trafficking and consumption in West Africa and their impact on security, governance and public health.

Since leaving the United Nations, he has been actively pressing for policies that will meet the needs of the

poorest and most vulnerable, particularly in Africa. Mr Annan is the Chair of The Elders, an independent

group of global leaders who work together for peace and human rights and is also a board member,

patron or honorary member of a number of organisations, including the United Nations Foundation. In

essence he continues to use his experience to mediate and resolve conflict.

@KofiAnnan


SPEA

KERS

’ BIO

GRA

PHIE

S

SPEA

KERS

’ BIO

GRA

PHIE

SNICK HAEKKERUP

Minister of Health

Denmark

Nick Hækkerup was appointed the Minister for Health of Denmark in February 2014. He has been a

Member of Parliament for the Social Democratic Party since 2007. Minister Hækkerup has held various

political positions, including Minister for Trade and European Affairs from August 2013 to February

2014 and Minister of Defence from October 2011 to August 2013. Aside from his political career,

Minister Hækkerup was the Clerk at The National Tax Tribunal and Assistant Professor at the University

of Copenhagen from 1998 to 2000, after receiving his PhD in Law in 1998.

@Nickerup

RT HON NORMAN LAMB MP

Minister of State for Care and Support, Department of Health

United Kingdom Norman Lamb was appointed Minister of State at the Department of Health in September 2012. He has

been the Liberal Democrat MP for North Norfolk since 2001. Minister Lamb has held various positions

in the Liberal Democrat party including Liberal Democrat Shadow Secretary of State for Health, 2006

to 2010. In May 2010 he was appointed Assistant Government Whip, as well as Chief Parliamentary and

Political Adviser and Parliamentary Private Secretary to the Leader of the Liberal Democrats and

Deputy Prime Minister, Nick Clegg. Outside his political career, Minister Lamb has worked for Norwich

City Council as a senior assistant solicitor before joining Norfolk solicitors Steele and Co, where he

became a partner and Head of the firm’s specialist Employment Unit.

@normanlamb

BEATRICE LORENZIN

Minister of Health

Department of Health, Italy

Beatrice Lorenzin was appointed Minister of Health in the Italian Government led by Enrico Letta in

2013. She started her political career in October 1997, with the election to the Council of XIIIth

Municipal district XIII of Rome. In May 2001, Minister Lorenzin was elected Town Councillor of Rome,

and between 2005 and 2006, she was Head of the Technical Secretariat of Undersecretary to the

Presidency of the Council of Ministers for Information and Publishing. Having been elected to the

Chamber of Deputies in 2008, she was reconfirmed in the Chamber in the general elections of February

2013. Minister Lorenzin was reconfirmed Minister of Health in the 63rd Government led by Matteo

Renzi in 2014.

@bealorenzin

MARY G BAKER

Immediate Past President

European Brain Council (EBC)

Along with her curent role, Mary Baker is also the EBC’S President of their ‘Year of the Brain’ project.

Dr Baker is also a member of the Strategic Advisory Board of the Human Brain Project and a member of

the Commission’s CONNECT Advisory Forum. Her academic appointments include Associate Membership

of the Health Services Research Unit, University of Oxford and Visiting Fellow within the London School

of Economics (LSE) Health Centre.

SUE BAKER

Director

Time to Change

Sue Baker leads Time to Change, England’s largest ever programme to end mental health stigma and

discrimination. She is responsible for leading and delivering this exciting social movement in England.

Time to Change is an ambitious £24 million programme (funded by the Department of Health, Comic

Relief and the Big Lottery Fund) being delivered by leading mental health charities, Mind and Rethink

Mental Illness. Ms Baker previously worked for the leading mental health charity in New Zealand

setting up marketing, campaigns and fundraising programmes, which aimed to address the

discrimination experienced by people with mental health problems using human rights and mental

health promotion models.

@suebakerTTC

ULRICH BIRNER

Head of Psychosocial Health and Well-being

Siemens

Ulrich Birner has vast experience in organisational and behavioural psychology. In his current position

his main responsibility and focus lies on the programme and measures used for maintaining, restoring

and fostering the psychosocial wellbeing and mental performance capability of the employees and

managers at Siemens.

@Siemens


SPEA

KERS

’ BIO

GRA

PHIE

S

SPEA

KERS

’ BIO

GRA

PHIE

S LOUISE BRADLEY

President and Chief Executive Officer

Mental Health Commission of Canada

Louise Bradley started her career as a registered nurse in Corner Brook, Newfoundland, where she

discovered an immediate passion for mental health. Ms Bradley came into her current role in 2010 after

serving as Senior Operating Officer for the University of Alberta Hospital, one of Canada’s leading

clinical, research and teaching hospitals. In 2012, she was awarded the Queen’s Diamond Jubilee Medal

in recognition of her outstanding contributions to the field of Canadian mental health. She also serves

on the Board of Directors for the Ottawa Humane Society. In her years of work, Ms Bradley has heard

from hundreds of Canadians living with mental illness and mental health problems. Their stories are

her inspiration to spark leading and lasting change for mental health care in Canada.

@LouiseBradleyMH

ALASTAIR CAMPBELL

Writer, Communicator and Strategist

Alastair Campbell is best known for his role as former British Prime Minister Tony Blair’s spokesman,

press secretary and Director of Communications and Strategy. Still active in politics in Britain and

overseas, he now splits his time between writing, speaking, charitable fundraising, consultancy and

campaigns. He has written ten books in the past seven years, including six volumes of diaries, three

novels, and a personal memoir on depression and the pursuit of happiness.

@campbellclaret

GEORGE N CHRISTODOULOU

Professor of Psychiatry and Chairman of the Department of Psychiatry, University of Athens, Greece;President, The World Federation for Mental Health

George Christodoulou has been in the Executive Committee of the World Psychiatric Association, where

he was responsible for the then 65 scientific sections of the WPA. He is currently the President of the

World Federation for Mental Health and of the Society of Preventive Psychiatry. In addition, Professor

Christodoulou is the author of many scientific papers and the editor of 40 books on a variety of

subjects. His publications contribute to psychiatric literature in many areas, but especially in

psychosomatic medicine, ethics, preventive psychiatry, disaster psychiatry and clinical psychiatry.

FRANCESCA COLOMBO

Head of Health Division

OECD

In her current position Francesca Colombo is responsible for OECD work on health, which aims at

providing internationally comparable data on health systems and applying economic analysis to health

policies, advising policy makers, stakeholders and citizens on how to respond to demands for more and

better health care. Ms Colombo was a Senior Health Policy Analyst in the Health Division and since

November 2013 has been acting Head of the Health Division. She has led projects on the performance

of health systems in OECD countries covering a wide range of topics, including quality of health care

policies, health financing and the impact of private health insurance on health systems, health

workforce and the international migration of doctors and nurses.

@OECD_Social

CHRISTOPHER DOWRICK

Professor of Primary Medical Care

University of Liverpool

Christopher Dowrick is GP and Professor of Primary Medical Care in the University of Liverpool, board

advisor for Mersey Care NHS Trust, NIHR Senior Investigator and Professorial Research Fellow in the

University of Melbourne. He has more than 30 years of experience in the mental health field, with over

200 scholarly publications including “Beyond Depression” (2009). He believes that the current trend to

medicalise unhappiness is too often an intrusion on personal emotions. It adds unnecessary

medication and costs, and distracts attention and resources from those who really need them.

@cfd1951

STEVE EVISON

Chair, European Federation of International Employers;Director, Employee Affairs EMEA, Ford Motor Company

Steve Evison joined the leading non-sectoral employers’ organisation for multinational employers in

2001 and has Chaired the board since 2007. He represents the Federation on the Advisory Group of the

Target Depression in the Workplace initiative, alongside other senior Human Resources and corporate

health and medical executives from major European employers and international organisations working

on health, labour and employment issues. Mr Evison joined Ford as a graduate trainee in 1990 at the

company’s Halewood manufacturing plant and he subsequently held a variety of Human Resources

roles within the UK. After senior UK and European Human Resources assignments, including a

secondment to Jaguar Land Rover, he served as Ford’s UK Human Resources Director before moving to

his present role in mid-2014.

@Ford


SPEA

KERS

’ BIO

GRA

PHIE

S

SPEA

KERS

’ BIO

GRA

PHIE

SDAVID HASLAM CBE

Chair

NICE (National Institute for Health and Care Excellence)

David Haslam was a family doctor for 36 years before taking up his current appointment. He was

formerly both the Chairman and President of the Royal College of General Practitioners. Dr Haslam was

awarded the CBE in 2004 for his services to Medicine and Health Care, and a Doctorate of the University

of Birmingham in 2014.

@NICEcomms

ULRICH HEGERL

President, European Alliance against Depression; Chair and Medical Director of the Department of Psychiatry, Leipzing University

Ulrich Hegerl is Chair and Medical Director of the Department of Psychiatry and Psychotherapy at

Leipzig University in Germany. He is also heading the European Alliance Against Depression and the

German Depression Foundation. Professor Hegerl’s research focus is on psychosocial and

neurobiological aspects of affective disorders and suicidal behaviour. He received the first prize

European Health Award for his continued work on the European Alliance Against Depression project.

DAVID KINDER

Deputy Director, Workforce, Pay and Pensions, Public Spending Group

HM Treasury

David Kinder’s team has overarching responsibility for the Government’s policy on pay and pensions

across the Public Sector, covering expenditure of around £170bn a year. Over the past 10 years David

has worked in various positions in the Cabinet Office, Treasury and the Department of Energy Climate

Change. Mr Kinder is also the Chair of the Treasury’s Mental Wellbeing Network.

PATRICK MCGORRY

Professor

Centre for Youth Mental Health, University of Melbourne

Patrick McGorry is Executive Director of Orygen Youth Health Research Centre (OYHRC) and Professor of

Youth Mental Health at the University of Melbourne, and was the 2010 “Australian of the Year”. OYHRC

comprises Australia’s largest youth mental health research centre and a linked clinical service

targeting the needs of young people with emerging serious mental illness. Professor McGorry and

OYHRC have put Australia at the forefront of research, innovation and transformational reform in early

intervention and youth mental health, creating prototypes, notably “EPPIC” and “headspace” on which

many other youth mental health services around the world are increasingly based.

@PatMcGorry

DAVID NUTT

President, European Brain Council (EBC);Professor of Neuropsychopharmacology and Head of the Neuropsychopharmacology Unit in the

Division of Brain Sciences Neuropsychopharmacology, Imperial College, London

Alongside his current appointment, David Nutt is also Chair of the Independent Scientific Committee

on Drugs (ISCD) and a Fellow of the Royal Colleges of Physicians, of Psychiatrists and of the Academy of

Medical Sciences. He has edited the Journal of Psychopharmacology for over 15 years and acts as the

psychiatry drugs advisor to the British National Formulary. Professor Nutt broadcasts widely to the

general public, both on radio and television, and has published over 400 original research papers,

reviews, 27 books and several government reports on drugs.

@ProfDavidNutt

LINDA ROSENBERG

President and Chief Executive Officer

National Council for Behavioral Health, USA

Linda Rosenberg is a national leader in the design and delivery of mental health and substance use

policy and services. Under her leadership, the National Council for Behavioural Health spearheads

advocacy, practice improvement, and public education initiatives to benefit the eight million adults,

children, and families served by the National Council’s 2,200 member organisations. Ms Rosenberg

helped secure passage of the federal mental health and addiction parity law and was critical to

ensuring that the Affordable Care Act addresses behavioural health disorders. Her vision expanded

financing for integrated behavioural and primary care services and built an array of organisational,

clinical and workforce initiatives. Ms Rosenberg introduced Mental Health First Aid in the US and to

date 250,000 citizens have been trained. Prior to joining the National Council, she was Senior Deputy

Commissioner of the New York State Office of Mental Health. Ms Rosenberg serves on an array of boards

of Directors and is a member of the Executive Committee of the National Action Alliance for Suicide

Prevention.

@linda_rosenberg

LORD DENNIS STEVENSON

former Chair, HBOS;Trustee, MQ: Transforming Mental Health

Lord Dennis Stevenson is the Founder and Chairman of MQ: Transforming Mental Health, a specialist

mental health research foundation established three years ago with the help of the Wellcome Trust. He

also introduced the Mental Health (Discrimination) Bill to the House of Lords which hit the statute

book in 2013. Aside from Lord Stevenson’s mental health interests, he has been a serial establisher of

businesses throughout his life, along with Chairing some large ones (Pearson, GPA, HBOS). He has also

done a number of jobs for government and in the not for profit sector (e.g. Chairman of the Trustees of

the Tate, Aldeburgh Music, Inter Mediate and NAYC etc.).

@joinMQ


SPEA

KERS

’ BIO

GRA

PHIE

S

SPEA

KERS

’ BIO

GRA

PHIE

S ELISABETH SVANTESSON

Deputy Chair, Committee on Social Insurance

Parliament, Sweden

Elisabeth Svantesson is the former Minister for Employment of Sweden. As a Moderate party member

her core focus was on the Labour market policy and working life. She is also the former Chair of the

Parliamentary Committee on the Labour Market and Vice Chair of the Bank of Sweden Tercentenary

Foundation. Ms Svantesson assumed her current role in the Swedish Parliament in late 2014.

ANDREAS TAUTZ

Chief Medical Officer

Deutsche Post DHLAs Chief Medical Officer, Andreas Tautz is responsible for the Health Management at Deutsche Post

DHL. He focuses on covering health related risks, the coordination of global health, and exercising

safety and wellbeing related activities in the group. Since joining the company in 1997, Dr Tautz has

taken on several positions in the fields of occupational health and general health management. Dr

Tautz is engaged in several National and International health-related networks and committees, and

holds a lectureship for Occupational Health at the Rheinische Friedrich-Wilhelms-Universität.

@DeutschePostDHL

SIMON WESSELY

Professor of Psychological Medicine at the Institute of Psychiatry

King’s College

Simon Wessely is an academic psychiatrist at King’s College London, where he is Chair of Psychological

Medicine. He has over 700 publications with a particular emphasis on the borders of medicine and

psychiatry, unexplained symptoms and syndromes, psychological treatments and military health. He is

Civilian Consultant Advisor in Psychiatry to the British Army in which capacity he has visited services in

Bosnia, Iraq and Afghanistan. In addition he is also a trustee of Combat Stress, the principal UK charity

for veterans with mental health problems. In 2012 Professor Wessley was awarded the first Nature

“John Maddox Prize” for Standing Up for Science, and was knighted in the 2013 New Year’s Honours

List for services to psychological medicine and military health. In 2014 he was elected President of the

Royal College of Psychiatrists.

@WesselyS

ULF WIINBERG

Chief Executive Officer

Lundbeck

Ulf Wiinberg has been holding his current role since 2008. Before joining Lundbeck, he worked with the

American medical corporation Wyeth/Lederle for 27 years and most recently served as President of

Wyeth Europe and Wyeth BioPharma. Mr Wiinberg has significant experience in working with trade

associations and is presently a board member of the European Federation of Pharmaceutical Industries

and Associations and the International Federation of Pharmaceutical Manufacturer Association. He is

also a member of Pharmaceutical Research and Manufacturers of America and serves as European

representative on the UK Ministerial Industry Strategy Group.

HANS-ULRICH WITTCHEN

Chairman and Director

Institute of Clinical Psychology and Psychotherapy, Center of Clinical Epidemiology and Longitudinal Studies (CELOS), Dresden Technical University

Hans-Ulrich Wittchen’s research combines in a unique way the psychological sciences and neuroscience

with epidemiological approaches as a “cornerstone methodology” in the field of disorders of the brain,

with emphasis on the developmental pathways of anxiety, depressive substance use disorders, as well

as neurological and somatic disease. He is and has been PI and Co-PI of several national and

international large-scale clinical epidemiological and family genetic studies on the prevalence, risk

factors, course and outcomes of mental and substance use disorders (EDSP; NGS, DEGS, WMH). Dr

Wittchen is also on the editorial board of several peer review journals and is the author of many books

and diagnostic instruments on mental and substance use disorders.


PRE-

EVEN

T PR

ESS

RELE

ASE

PRE-

EVEN

T PR

ESS

RELE

ASE

THE ECONOMIST EVENTS TO HOST CONFERENCE TO DEBATE THE URGENT NEED FOR A UNITED

RESPONSE TO THE GLOBAL DEPRESSION CRISIS

London 2014

More than 200 international policymakers, senior business leaders, academics, and patient advocates,

are convening in London on November 25th to discuss the urgent need for a global response to the

increasing impact of depression. The Conference entitled ‘The Global Crisis of Depression – The Low of

the 21st Century’ will discuss the global burden of depression, which now affects more than 350 million

peopleand address the need for a global approach, aiming to tackle an issue that has become the

leading cause of disability worldwide. In Europe, 1 in 10 employees have missed work due to

depression. “Depression is so pervasive that it escapes no one. We all know it intimately or we know

people living with it. There’s help, but we need to better pave that path. This disease is not a part of

normal life,” said Linda Rosenberg, President and Chief Executive Officer, National Council for

Behavioral Health, USA

Kofi Annan, former Secretary General, United Nations, will open the Conference, which will include

keynote speaker presentations on the burden of depression on society, the need for new advances in

treatment, the challenge of depression in the workplace, and how stakeholders from all strata of

society must come together to address the impact of depression.

Key speakers include:

• KOFI ANNAN, former Secretary General, United Nations; Chairman, Kofi Annan Foundation

• RT HON NORMAN LAMB MP, Minister of State for Care and Support, United Kingdom

• NICK HÆKKERUP, Minister of Health, Denmark

• BEATRICE LORENZIN, Minister of Health, Italy

• ALASTAIR CAMPBELL, Communicator, Writer, Strategist

• DAVID HASLAM, Chair, NICE (National Institute for Health and Care Excellence)

• FRANCESCA COLOMBO, Head of Health Division, OECD

• LORD DENNIS STEVENSON, former Chair, HBOS; Trustee, MQ: Transforming Mental Health

The Global Crisis of Depression is organised by The Economist Events, and sponsored by Lundbeck. For

the latest programme, please visit www.depression.economist.com. You can also join us on

Twitter at #depressionsummit and @EconomistEvents. For press accreditation enquiries please

contact: [email protected].


DEPR

ESSI

ON

FA

CTSH

EET

DEPR

ESSI

ON

FA

CTSH

EET DEPRESSION FACTSHEET

Depression is the biggest mental health challenge among people of working-age, and the leading

cause of disability worldwidei.

More than 30 million people in Europe are affected by depression, most of whom are working ageii.

On a global level, depression, the leading cause of disability worldwideiii, affects 350 million peopleiv.

Depression has significant socio-economic costs. The costs of depression in the EU were estimated at

€92 billion in 2010, with the majority (€54 billion) being indirect such as lost work productivity due

to, for example, sick leave and early retirementv.

The cognitive symptoms of depression - concentration difficulties, indecisiveness, and/or

forgetfulness - are present up to 94% of the time in an episode of depression and cause significant

impairment in work functionvi. People with depression report on average 5.6 hours per week of total

health-related lost productivity time (LPT) more than those without depression - eighty-one percent

of those LPT costs are explained by reduced performance while at work, i.e. presenteeismvii.

1 in 10 workers has taken time off work due to depression, with 36 working days lost per depressive

episode. Yet, in spite of this, one in three managers say they do not have formal support or resources

to deal with the problemviii.

According to a recent report by the London School of Economics and Political Science and King’s

College London, the cost of depression to European businesses is estimated at £77 billion per year,

with the greatest loss attributed to absenteeism (frequent absence from work) and lost

productivityix.

More than half of patients do not achieve adequate response following first antidepressant

treatment and remission rates are progressively lower for each successive treatment step, which

highlight the need to provide effective therapies early in depression treatmentx.

According to the OECD’s recent report on mental health, there is an extremely large treatment gap

within depression, with a median 56.3%xi. As result, the OECD recommends that governments

strengthen and scale-up treatment for depression.

Studies show that the costs of treating depression are outweighed by productivity benefits in terms

of reduced rates of absenteeism and presenteeism (attending work whilst unwell)xii. For example,

data from the UK show that every Pound invested in early diagnosis and treatment of depression at

work will yield a cross-sector return of £5xiii.

But the benefits extend beyond employer bottom lines. The early identification and optimum

management of depression and its cognitive symptoms (trouble concentrating, indecisiveness,

forgetfulness) will help people with depression receive appropriate treatment to facilitate recovery

and return to work, bringing benefits from a social, family and economic perspectivexiv.

The longer depression goes untreated, the more debilitating the condition becomes, which in turn

leads to even greater strain on national disability funds .

Research has shown that people experiencing major depression have an 11% decline in work

productivity due to increased confusion, inattention, memory issues, apathy and sleep dysfunction .

i World Health Organisation. Depression Factsheet. Available at: http://www.who.int/mediacentre/factsheets/fs369/en/

ii Evans-Lacko S, Knapp M. Importance of Social and Cultural Factors for Attitudes, Disclosure and Time off Work for Depression: Findings from a Seven Country European Study on Depression in the Workplace. PLOS One. DOI: 10.1371/journal.pone.0091053

iii World Health Organisation. Depression Factsheet. Available at: http://www.who.int/mediacentre/factsheets/fs369/en/

iv European Pact for Mental Health and Well-being, 2008; J. Olesen, et al. Eur J Neurology. 2012;19:155–162

v J. Olesen, et al. Eur J Neurology. 2012;19:155–162

vi J. Olesen, et al. Eur J Neurology. 2012;19:155–162

vii Stewart WF, et al. JAMA, 2003;289(23):3135–3144

viii European Depression Association (EDA), Impact of Depression in Europe Audit Survey (IDEA Survey), 2012

ix Evans-Lacko S, Knapp M. Importance of Social and Cultural Factors for Attitudes, Disclosure and Time off Work for Depression: Findings from a Seven Country European Study on Depression in the Workplace. PLOS One. DOI: 10.1371/journal.pone.0091053

x Rush AJ et al. Am J Psychiatry 2006 Nov;163(11):1905-17.

xi OECD, 2014, Making Mental Health Count

xii Kessler RC et al. Depression in the workplace: effects on short-term disability. Health Affairs. September 1999 vol. 18 no. 5 163–171; Simon GE et al. Depression and Work Productivity: The Comparative Costs of Treatment Versus Nontreatment. Journal of Occupational & Environmental Medicine. January 2001;43(1):2–9; Knapp M et al. Mental Health Promotion and Prevention: The Economic Case. January 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215626/dh_126386.pdf

xiii European Commission report 2011. Mental well-being: For a smart, inclusive and sustainable Europe. http://ec.europa.eu/health/mental_health/docs/outcomes_pact_en.pdf

xiv Naismith SL et al. Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry 2007: 7:32; Zhang M et al. A Community Study of Depression Treatment and Employment Earnings. Psychiatric Services. September 1999.

xv Sick on the job? Myths and Realities about Mental Health and Work. OECD, 2012.

xvi Stephens T et al. The Economic Burden of Mental Health Problems in Canada. Chronic Dis Can. 2001;22(1):18–23; Lerner D et al. The clinical and occupational correlates of work productivity loss among employed patients with depression. J Occup Environ Med. 2004 Jun;46(6 Suppl):S46–55.

Factsheet from our sponsor:

@EconomistEvents #depressionsummit

SPO

NSO

R PR

OFI

LE

H. Lundbeck A/S is a global pharmaceutical company specialized in brain diseases. For more than 50

years, we have been at the forefront of research within neuroscience. Our key areas of focus are alcohol

dependence, Alzheimer’s disease, bipolar disorder, depression/anxiety, epilepsy, Huntington’s disease,

Parkinson’s disease, schizophrenia, stroke and symptomatic neurogenic orthostatic hypotension

(NOH).

An estimated 700 million people worldwide are living with brain disease and far too many suffer due to

inadequate treatment, discrimination, a reduced number of working days, early retirement and other

unnecessary consequences. Every day,we strive for improved treatment and a better life for people

living with brain disease – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind.

Our approximately 6,000 employees in 57 countries are engaged in the entire value chain throughout

research, development, production, marketing and sales. We have research centres in China, Denmark

and the United States and production facilities in China, Denmark, France and Italy.

For additional information, we encourage you to visit our corporate site www.lundbeck.com

More than 700 million people are affected by brain disease worldwide - this is equal to 13% of the global disease burden.1

Prevalent disorders such as depression, dementia and addiction account for 35% of Europe’s total disease burden.2,3,4

The European Brain Council estimates that the cost of brain diseases is € 798 billion in Europe alone.2,3,4

All over the world, brain disease is a growing burden, not only for individuals but for families and societies as well.

An estimated 700 million people worldwide are living with brain disease and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences.

Lundbeck is a specialized pharmaceutical company focusing on brain disease. For more than 50 years, we have been at the forefront of research within neuroscience and our development and distribution of pioneering treatments continues to

make a difference to people living with brain disease.

We are recognized for having helped hundreds of millions of people suffering from brain disease, such as depression, alcohol dependence, schizophrenia, epilepsy, and Alzheimer’s, Parkinson’s and Huntington’s disease. However, there is still a massive need for help.

Every day, we strive for improved treatment and a better life for people living with brain disease – we call this Progress in Mind.

www.lundbeck.com/global/about-us/progress-in-mind

Facts about brain disease

1. www.ifpma.org/fileadmin/content/Global%20Health/Mental_Health/2012_IFPMA_Position_Paper_on_MNDs.pdf2. Gustavsson et al. –Cost of disorders of the brain in Europe 2010. 3. European Neuropharmacalogy, 2011.& Wittchen, H.U. et al. – The size and burden of mental disorders and other disorders of the brain in Europe, 2011. 4. WHO Mental Health Atlas 2011

Why do almost 50% of people with brain diseases not receive any treatment?


Abu Dhabi, Ahmedabad, Amsterdam, Atlanta, Austin, Bangalore, Barcelona, Beijing, Berlin, Brussels, Buenos Aires, Calgary, Chennai, Chicago, Dallas, Dubai, Dublin, Frankfurt, Guangzhou, Hamburg, Ho Chi Minh City, Hong Kong, Houston, Hyderabad, Istanbul, Jakarta, Johannesburg, Kolkata, Kuala Lumpur, London, Los Angeles, Madrid, Melbourne, Mexico City, Miami, Milan, Montreal, Moscow, Mumbai, Munich, New Delhi, New York, Orlando, Paris, Pegasus Beijing, Pegasus Shanghai, Portland, Pune, Rio de Janeiro, Rome, Sacramento, San Francisco, São Paulo,

Seattle, Seoul, Shanghai, Silicon Valley, Singapore, Stockholm, Sydney, Taipei, Tokyo, Toronto, Vancouver, Warsaw, Washington, D.C., Zurich

INDEPENDENCEWith over 5,000 people in 65 countries around the world, we’ve become the industry leader by focusing on

what’s best for our clients and giving our talent the freedom to flourish. Put our independence to work for you.

SHOW UP DIFFERENTLY

#ShowUpDifferently Learn more at www.Edelman.com

Edelman Independence A4 Ad Nov 2014.indd 12 05/11/2014 18:59

OFFICIAL PR AGENCY

edelman.com

MEDIA PARTNERS AND SUPPORTING ORGANISATIONS

europeanvoice.com

wfmh.com

gamian.eu

SUPP

ORT

ERS

the global crisis of depression - lundbeck depression... · the global crisis of depression ... the...

Documents